By 2033, the IV fluid transfer pharmaceutical devices market is projected to grow to a value of US$ 9,250.9 million worldwide. Through 2033, IV fluid transfer pharmaceutical device manufacturers project a 3.4% compound annual growth rate (CAGR) for the market. In 2023, it is anticipated that the market valuation would amount to US$ 6,652.7 million. …
Category Archives: Healthcare Trends
Homecare Medical Devices Market Envisions a Share of US$ 312,328.055 Million by 2032, Paving the Way for Personalized Healthcare Solutions
The global homecare medical devices market share is expected to reach US$ 133650.67 million in 2022 and US$ 312328.055 million by 2032, growing at an 8.9% CAGR over the projected period. Revolutionizing healthcare delivery, the Homecare Medical Devices Market emerges as a beacon of convenience and empowerment. Designed for in-home use, these devices encompass a …
Glioblastoma Treatment Drugs Market Envisions a Valuation Soaring to US$1,317.4 Million by 2033, Illuminating the Path to Enhanced Therapeutic
The glioblastoma treatment drugs market is projected to be worth US$ 1,317.4 million by 2033, up from US$ 756.1 million in 2023. Over the course of the projected period, the global market is anticipated to grow at a CAGR of 5.7%. As a crucial sector in the battle against glioblastoma, a highly aggressive form of …
Graft Versus Host Disease (GvHD) Treatment Market Sets Sail, Anticipating a Soar to US$5,960.7 Million by 2033, Navigating the Landscape of Therapeutic Solutions
The graft versus host disease (GvHD) treatment market is anticipated to grow at a strong 8.2% (CAGR) during the coming years. By 2033, it is expected to have a sizable market size of US$ 5,960.7 million. As of 2023, the market is already valued at a significant US$ 2,713.6 million. Navigating the delicate interplay between …
Global Companion Diagnostics Industry is set to achieve sales totaling US$ 10,560.0 Million by the year 2033 at a CAGR of 7.0% | FMI
The global companion diagnostics industry growth is expected to generate US$ 10,560.0 million in sales by 2033, up from US$ 5371.9 million in 2023. During the forecast period, the companion diagnostics industry may blossom at a CAGR of 7.0%. A rapidly expanding area of personalised medicine is the companion diagnostics market. Companion diagnostics are medical …
Global Endoscopic Closure Systems Industry is poised for a persistent 6.3% CAGR at US$ 570.2 Million by 2033 | FMI
The global endoscopic closure systems industry demand sales are expected to be valued at US$ 309.2 million in 2023, exhibiting a CAGR of 6.3% at US$ 570.2 million from 2023 to 2033. The endoscopic closure systems industry expanded at a CAGR of 4.1% from 2018 to 2022. Growing demand for endoscopy to identify and treat …
Global Electric Acupuncture Devices Industry is expected to achieve a considerable US$ 27.5 Million by 2033 capturing a CAGR of 7.1% | FMI
The global electric acupuncture devices industry growth is projected to be worth US$ 13.9 million in 2023 and US$ 27.5 million from 2023 to 2033, capturing a CAGR of 7.1%. The electric acupuncture devices industry is anticipated to expand significantly in the upcoming years due to rising demand for non-invasive treatments and rising public awareness …
Global Dialysis Devices and Concentrates Industry is projected to be worth US$ 34,824.85 Million by 2033, spotlighting the commitment to pioneering patient-centric renal solutions | FMI
According to forecasts, the global dialysis device and concentrates industry demand is expected to be US$ 21,663.5 million in 2023 and US$ 34,824.85 million by 2033, forecast a CAGR of 4.9%. Key Players increasingly focus on strategic agreements/partnerships with regional/domestic players to increase their presence in these markets and tap many customers. Market participants focus …
Dental Piezoelectric Ultrasonic Unit Market Powers Ahead with a Projected 5.2% CAGR, Unleashing Advanced Dental Technology
The dental piezoelectric ultrasonic unit market share is expected to develop at a 5.2% compound annual growth rate (CAGR) during the course of the forecast period, signalling the approaching occurrence of a significant transformation. The market is expected to generate approximately US$ 216.9 million in sales by 2023 and US$ 361.1 million in revenue by …
Global Arteriovenous Fistula Treatment Industry is expected to experience sustained growth of a 5.9% CAGR, potentially reaching US$ 1,356.5 Million by 2033 | FMI
The global arteriovenous fistula treatment industry demand value is anticipated to increase significantly from the current value of US$ 765.8 million in 2023. Arteriovenous fistula therapy is becoming more widely used, which is expected to propel market expansion at a consistent CAGR of 5.9% throughout the forecast period. The demand for treating arteriovenous fistulas is …